A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases ...

A new University of Michigan study shows that a strong majority of older Americans want health insurance — including Medicare — to cover weight loss medica ...

State lawmakers are considering expanding the types of obesity treatments covered by Nevada Medicaid, including approving ...

Fashion influencer Remi Bader just revealed she underwent a weight loss surgery that cut 80 percent of her stomach amid ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

are denied coverage for anti-obesity medications, even though these treatments have been shown to reduce weight, improve overall health, prevent or manage obesity-related conditions, and for some ...

A Prime Therapeutics analysis of real-world data has found that medical costs for patients taking GLP-1 drugs for obesity had increased by about $1,338 per member, compared with a matched control ...

Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what ...

Mounjaro, a weight loss drug launched by Eli Lilly in India, could be a game-changer and has been making waves lately. Here's ...

Eli Lilly launches diabetes and obesity drug Mounjaro in India, offering innovative treatment for metabolic health management ...

A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases in life expectancy and disease-free years while generating a ...